rs576098128
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM5BP4_Moderate
The NM_003673.4(TCAP):c.317G>A(p.Arg106His) variant causes a missense change. The variant allele was found at a frequency of 0.0000143 in 1,612,928 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R106C) has been classified as Benign.
Frequency
Consequence
NM_003673.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TCAP | NM_003673.4 | c.317G>A | p.Arg106His | missense_variant | 2/2 | ENST00000309889.3 | NP_003664.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TCAP | ENST00000309889.3 | c.317G>A | p.Arg106His | missense_variant | 2/2 | 1 | NM_003673.4 | ENSP00000312624 | P1 | |
TCAP | ENST00000578283.1 | c.245G>A | p.Arg82His | missense_variant | 3/3 | 5 | ENSP00000462787 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000401 AC: 10AN: 249188Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135270
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1460590Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 726626
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152338Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74478
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Agnes Ginges Centre for Molecular Cardiology, Centenary Institute | Oct 16, 2018 | TCAP Arg106His has not been previously reported but is present multiple times in both the Exome Aggregation Consortium dataset (AF= 0.00004315; http://exac.broadinstitute.org/) and in the Genome Aggregation Database (AF= 0.00003989; http://gnomad.broadinstitute.org/) suggesting that this may be a benign polymorphism. We identified this variant in a HCM proband with no family history of disease. In silico tools SIFT and MutationTaster predict this variant to be deleterious but PolyPhen2 predicts this variant to be benign. Based on the conflicting evidence we classify TCAP Arg106His as a variant of 'uncertain significance'. - |
Primary familial hypertrophic cardiomyopathy;C4225408:Hypertrophic cardiomyopathy 25 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 18, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The histidine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 568632). This variant has not been reported in the literature in individuals affected with TCAP-related conditions. This variant is present in population databases (rs576098128, gnomAD 0.04%). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 106 of the TCAP protein (p.Arg106His). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at